JAN 18, 2020 8:22 PM PST

Drug Combo Targets Osteoarthritis

WRITTEN BY: Nouran Amin

Individuals suffering from osteoarthritis often face challenges of limited treatment options mainly pain relievers or joint replacement surgery. However, scientists using rat models have recently discovered a powerful drug combination that can reverse the cellular and molecular signs of osteoarthritis. The effects of these drugs were also demonstrated in isolated human cartilage cells.

Findings were published in the journal Protein & Cell.

"What's really exciting is that this is potentially a therapy that can be translated to the clinic quite easily," says Juan Carlos Izpisua Belmonte, lead author and a professor in Salk's Gene Expression Laboratory. "We are excited to continue refining this promising combination therapy for human use."

Osteoarthritis is caused by changes in the bone and cartilage cells and is the most common joint disorder and currently affects 30 million adults—it is expected that the disease will rise as a result of the aging population and the increasing rate of obesity. Aging and repeated stress can cause molecules and genes in the cells of articular cartilage to eventually breakdown leading to pain and stiffness.

Learn more about osteoarthritis:

Old studies have confirmed two major drugs that can treat osteoarthritis--alpha-KLOTHO and TGF beta receptor 2 (TGFβR2). These drugs support the growth and strength of articular cartilage cells when worked together as opposed to used alone in treatment. When add as therapeutic combo, they are most effective.

"We thought that by mixing these two molecules that work in different ways, maybe we could make something better," says Paloma Martinez-Redondo, a Salk postdoctoral fellow and co-first author of the new study.

The rats used in the study carried viral particles that enclosed DNA instructions for making αKLOTHO and TGFβR2.

"From the very first time we tested this drug combination on just a few animals, we saw a huge improvement," says Isabel Guillen-Guillen, the paper's co-first author. "We kept checking more animals and seeing the same encouraging results."

In the cartilage cells, experiments confirmed 136 genes that were more active and 18 genes that were less active.

"That's not the same as showing how these drugs affect the knee joint in humans, but we think it's a good sign that this could potentially work for patients," says Martinez-Redondo.

"We think that this could be a viable treatment for osteoarthritis in humans," says Pedro Guillen, director of the Clinica CEMTRO and co-corresponding author.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
MAY 21, 2020
MAY 21, 2020
A New Player in the Regulation of Cancer's Microenvironment
Breast cancer is one of the most common cancers in the world.  Triple-negative breast cancer (TNBC) is a sub-type o ...
JUN 02, 2020
Cannabis Sciences
JUN 02, 2020
Ancient Israelites Used Cannabis to Experience God
Researchers have found evidence that ancient worshipers in Israel may have used cannabis to experience God over 2800 yea ...
JUN 04, 2020
JUN 04, 2020
Inhibiting the Signals Critical for Cancer Growth in Merkel Cell Carcinoma
Merkel Cell Carcinoma (MCC) is a highly aggressive cancer of the skin. It is characterized by a high recurrence rate and ...
JUN 13, 2020
JUN 13, 2020
High Doses of Ketamine Can Switch Off the Brain
Researchers from the University of Cambridge, England, have found that high doses of ketamine temporarily switch off the ...
JUN 18, 2020
Drug Discovery & Development
JUN 18, 2020
A Fat Burning Molecule That Works?
Obesity is a US epidemic affecting more than 40 percent of the adults and with a wide array of complications one being e ...
JUL 01, 2020
Health & Medicine
JUL 01, 2020
New Venture Will Commercialize Products From Cannabis Research
Though the history of cannabis dates back at least three thousand years, the workings of the endocannabinoid system-the ...
Loading Comments...